PulmoLife™ COPD Monitor

Because early detection and treatment of COPD, especially in smokers, can positively influence the disease course, it is important to screen those patients at risk. PulmoLife is the ideal tool to use as a quick check of lung function to highlight early signs of disease.

PulmoLife is suitable for FEV1 testing programs, identification of early signs of COPD in smokers over 35, and encouraging susceptible smokers to quit.

Features & Benefits

  • Quick and easy-to-use
  • Large visual display and step-by-step screening instructions
  • Accurate and easy-to-clean turbine
  • Provides a clearly visible display of FEV1 and FEV1% - FEV1 is strongly recommended as the measurement of choice in COPD screening and the percent of predicted values can be used to help determine the level of severity of disease.
  • The monitor calculates Lung Age to show smokers the damage they have caused to their lungs, especially beneficial for patient education and encouragement.

Please note, all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative. The information provided in this site is intended for healthcare professionals.

0123

The Latest News From Vyaire

Brexit Statement

As Brexit approaches, Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, continues to evaluate and prepare for the impact of the United Kingdom’s (UK) withdrawal from the European Union (EU) on our operations.

Read More
Vyaire Statement on imtmedical ag / Hamilton Patent Dispute

On June 17, 2020, the Swiss Supreme Court denied an appeal brought by imtmedical ag regarding a long-standing Swiss patent dispute concerning certain flow sensor types.

Read More

Contact a Sales Representative